This clinical challenge discusses a case in which a patient was referred for aortic valve repair or replacement due to severe aortic regurgitation from infective endocarditis. In addition to discovering a previously unknown tricuspid valve vegetation, the intraoperative echocardiographic evaluation was instrumental in revealing an undiagnosed Gerbode defect. The flow through this Gerbode defect was previously mistaken for tricuspid regurgitation, and the patient was misdiagnosed as exhibiting severe pulmonary hypertension. This case highlights the importance of reviewing preoperative echocardiographic imaging, as well as diligence in completing a thorough intraoperative transesophageal echocardiographic exam prior to cardiopulmonary bypass. In addition, while flow typically occurs in Gerbode defects during systole, this case demonstrates that flow can also occur during diastole, which was most likely due to the severe aortic regurgitation. Fortunately, the patient was able to undergo successful treatment for the unexpected sequalae of the infective endocarditis, including repair of the Gerbode defect, tricuspid valve repair, and aortic valve and root replacement. Importantly, the incorrect diagnosis of severe pulmonary hypertension was removed.

Download full-text PDF

Source
http://dx.doi.org/10.1177/10892532221080920DOI Listing

Publication Analysis

Top Keywords

gerbode defect
16
aortic valve
12
intraoperative transesophageal
8
transesophageal echocardiographic
8
patient referred
8
referred aortic
8
valve repair
8
severe aortic
8
aortic regurgitation
8
infective endocarditis
8

Similar Publications

Circular Shunt: A Loop Not to Be Ignored.

J Cardiothorac Vasc Anesth

December 2024

Department of Cardiothoracic Surgery, National Heart Center, Royal Hospital, Muscat, Oman.

A circular shunt, initially described by Shone et al. in 1962, refers to abnormal blood recirculation through complete intracardiac or intra- and extracardiac communications, bypassing the capillary beds. This pathophysiological condition is most commonly associated with complex congenital heart defects, such as Ebstein's malformation, pulmonary atresia, Gerbode defect, and so on.

View Article and Find Full Text PDF

Background: In clinical practice, intravascular hemolysis is not common after interventional cardiovascular procedures. Although diagnostic and treatment techniques have developed, with the increasing importance placed on people's own health and the popularity of cardiovascular intervention, there have been occasional reports of hemolysis after different cardiovascular interventions, mainly including cardiac pacemaker implantation, atrial-fibrillation radiofrequency ablation, transcatheter aortic-valve implantation (TAVI), transcatheter mitral valve replacement (TMVR) and percutaneous repair of Gerbode defect and percutaneous coronary intervention (PCI) with Impella. However, so far, there have been no relevant reports on postoperative hemolysis after percutaneous coronary intervention (PCI).

View Article and Find Full Text PDF

A case report of Ebstein's anomaly-Gerbode defect dyad: is there room for another anomaly in the same patient?

Eur Heart J Case Rep

September 2024

Department of Internal Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 5th Dept. of Internal Medicine, Medical Clinic No.1, 40006 Cluj-Napoca, Romania.

Article Synopsis
  • - Ebstein's anomaly is a rare heart condition where the tricuspid valve is positioned unusually low in the heart and is often linked to other heart defects.
  • - A case involving a 50-something man with Ebstein's anomaly and a rare combination with a septal defect (Gerbode defect) was discovered through MRI, along with an unusual origin of his right coronary artery.
  • - Despite having several congenital issues, the patient had few symptoms until developing atrial flutter, which was successfully treated with catheter ablation, highlighting the importance of advanced imaging for diagnosis.
View Article and Find Full Text PDF

Off-label uses of the Amplatzer Piccolo Occluder in children with congenital and acquired heart diseases.

Future Cardiol

October 2024

Department of Pediatrics, Division of Cardiology, University of Tennessee Health Science Center, Le Bonheur Children's Hospital, Memphis, TN, USA.

The Amplatzer Piccolo Occluder (APO) is approved for patent ductus arteriosus (PDA) occlusion in infants weighing >700 g but could offer versatility to treat other lesions. Retrospective review of children in whom APO was utilized for defects other than PDA between January 2022 and June 2023. The APO was used in nine patients; three for ventricular septal defects, four with coronary fistulas, one for a ventricular pseudoaneurysm and one where APO deployed within a fenestration of a previously placed Amplatzer Septal Occluder.

View Article and Find Full Text PDF

Introduction: The study aims to assess the procedural outcomes and follow-up after transcatheter closure of ventricular septal defects (VSDs) in children utilizing the Konar-MF™ occluder (Lifetech Scientific, Shenzhen, PRC) device.

Materials And Methods: Clinical features, demographic characteristics, and follow-up findings of children undergoing percutaneous VSD device closure were retrospectively analyzed from the medical records.

Results: Fifty-seven patients underwent VSD closure using the Konar-MF occluder between January 2019 and April 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!